Creative medical technology holdings provides corporate update

Phoenix--(business wire)--creative medical technology holdings, inc., (“creative medical technology” or the “company”) (nasdaq: celz), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, today provided a corporate update in connection with the filing of its form 10-k on march 22, 2024. “in the past year our achievements have been some of the most consequential in the history of creative medical technology,” said timot.
CELZ Ratings Summary
CELZ Quant Ranking